Syncom Formulations (India) standalone net profit declines 31.51% in the March 2022 quarter

19 May 2022 , 08:06 AM

Net profit of Syncom Formulations (India) declined 31.51% to Rs 4.76 crore in the quarter ended March 2022 as against Rs 6.95 crore during the previous quarter ended March 2021. Sales declined 11.15% to Rs 58.23 crore in the quarter ended March 2022 as against Rs 65.54 crore during the previous quarter ended March 2021. For the full year,net profit declined 32.16% to Rs 19.79 crore in the year ended March 2022 as against Rs 29.17 crore during the previous year ended March 2021. Sales declined 10.27% to Rs 219.66 crore in the year ended March 2022 as against Rs 244.81 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	58.23	65.54	-11	219.66	244.81	-10
OPM %	3.25	12.85	–	8.86	15.45	–
PBDT	6.70	11.99	-44	30.11	44.70	-33
PBT	5.69	10.94	-48	26.16	40.67	-36
NP	4.76	6.95	-32	19.79	29.17	-32

Powered by Capital Market – Live News